VertiFlex will focus attentions on the Superion product line, which is currently scheduled for upcoming clinical trials. The Superion Interspinous Spacer is a percutaneous titanium implant fitting between the spinous processes in the lumbar spine.
Read the VertiFlex news release on the sale of the Silverbolt product portfolio.
Read other coverage on VertiFlex:
– VertiFlex Announces 100th Patient Enrolled in Superion IDE Trial
– Dr. George Rappard First in the U.S. to Present Superion Interspinous Spacer Clinical Results
– Spine Surgeon First in Pennsylvania to Implant Device to Treat Leg Pain Caused by Spinal Stenosis
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.